The cardiovascular outcomes trial SUSTAIN-6, published in the New England Journal of Medicine, demonstrated cardiovascular safety in a population where many participants were receiving antiplatelet therapy
The combined benefits of reduced appetite, increased satiety, slower gastric emptying, and improved blood sugar control make GLP-1 therapy an effective weight loss solution, particularly for individuals who have found it challenging to lose weight with diet and exercise alone
$99 peptide therapy and wellness consultation available for eligible patients
The body goes through several changes while losing weight, and multiple triggers can overlap
For instance, changes in appetite or mood caused by Prozac could impact eating habits, which can, in turn, influence blood sugar control